Thrombocytopenia in pregnancy.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The implications of thrombocytopenia in pregnancy vary with the etiology of the thrombocytopenia. This article focuses on defining what those etiologies are and assessing risk and therapy for each. Most important, the need to diagnose the largest and most benign entity of incidental thrombocytopenia is emphasized so that patients can be reassured and not subjected to further intervention. The angiopathic entities of preeclampsia, HELLP syndrome (hemolytic anemia, elevated liver function tests, and low platelets), disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic-uremic syndrome may also cause severe thrombocytopenia. The controversy surrounding the particular therapeutic dilemma of immune thrombocytopenic purpura is explored, with evaluation of the actual danger to the mother, method of delivery, and treatment for the neonate. The serious nature of alloimmune thrombocytopenia is emphasized, and current modes of risk assessment and therapy are discussed.

Original languageEnglish (US)
Pages (from-to)117-122
Number of pages6
JournalJournal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians
Volume5
Issue number3
StatePublished - 1994

Fingerprint

Thrombocytopenia
Pregnancy
HELLP Syndrome
Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
Idiopathic Thrombocytopenic Purpura
Disseminated Intravascular Coagulation
Liver Function Tests
Hemolytic Anemia
Therapeutics
Pre-Eclampsia
Blood Platelets
Mothers
Newborn Infant

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{e25c8a2806a348b898370e686cb53731,
title = "Thrombocytopenia in pregnancy.",
abstract = "The implications of thrombocytopenia in pregnancy vary with the etiology of the thrombocytopenia. This article focuses on defining what those etiologies are and assessing risk and therapy for each. Most important, the need to diagnose the largest and most benign entity of incidental thrombocytopenia is emphasized so that patients can be reassured and not subjected to further intervention. The angiopathic entities of preeclampsia, HELLP syndrome (hemolytic anemia, elevated liver function tests, and low platelets), disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic-uremic syndrome may also cause severe thrombocytopenia. The controversy surrounding the particular therapeutic dilemma of immune thrombocytopenic purpura is explored, with evaluation of the actual danger to the mother, method of delivery, and treatment for the neonate. The serious nature of alloimmune thrombocytopenia is emphasized, and current modes of risk assessment and therapy are discussed.",
author = "Billett, {Henny H.}",
year = "1994",
language = "English (US)",
volume = "5",
pages = "117--122",
journal = "Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians",
issn = "1048-9886",
publisher = "Emron",
number = "3",

}

TY - JOUR

T1 - Thrombocytopenia in pregnancy.

AU - Billett, Henny H.

PY - 1994

Y1 - 1994

N2 - The implications of thrombocytopenia in pregnancy vary with the etiology of the thrombocytopenia. This article focuses on defining what those etiologies are and assessing risk and therapy for each. Most important, the need to diagnose the largest and most benign entity of incidental thrombocytopenia is emphasized so that patients can be reassured and not subjected to further intervention. The angiopathic entities of preeclampsia, HELLP syndrome (hemolytic anemia, elevated liver function tests, and low platelets), disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic-uremic syndrome may also cause severe thrombocytopenia. The controversy surrounding the particular therapeutic dilemma of immune thrombocytopenic purpura is explored, with evaluation of the actual danger to the mother, method of delivery, and treatment for the neonate. The serious nature of alloimmune thrombocytopenia is emphasized, and current modes of risk assessment and therapy are discussed.

AB - The implications of thrombocytopenia in pregnancy vary with the etiology of the thrombocytopenia. This article focuses on defining what those etiologies are and assessing risk and therapy for each. Most important, the need to diagnose the largest and most benign entity of incidental thrombocytopenia is emphasized so that patients can be reassured and not subjected to further intervention. The angiopathic entities of preeclampsia, HELLP syndrome (hemolytic anemia, elevated liver function tests, and low platelets), disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic-uremic syndrome may also cause severe thrombocytopenia. The controversy surrounding the particular therapeutic dilemma of immune thrombocytopenic purpura is explored, with evaluation of the actual danger to the mother, method of delivery, and treatment for the neonate. The serious nature of alloimmune thrombocytopenia is emphasized, and current modes of risk assessment and therapy are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0028310167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028310167&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 117

EP - 122

JO - Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians

JF - Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians

SN - 1048-9886

IS - 3

ER -